XML 87 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Intangible Assets and Goodwill (Schedule of Intangible Assets and Goodwill) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months $ 298.0  
Intangible Assets, Cost 4,778.4 $ 4,760.4
Intangible Assets, Accumulated Amortization 1,434.1 1,119.1
Intangible assets, net 3,344.3 3,641.3
Goodwill, Cost 5,040.3 5,040.3
Goodwill, Accumulated Amortization 2.9 2.9
Goodwill 5,037.4 5,037.4
Licensing Agreements    
Intangible Assets [Line Items]    
Finite-lived Intangible Assets, Cost 57.0 39.0
Finite-lived Intangible Assets, Accumulated Amortization (34.7) (29.3)
Finite-lived Intangible Assets, Net 22.3 9.7
Patents [Member]    
Intangible Assets [Line Items]    
Finite-lived Intangible Assets, Cost 10.5 10.5
Finite-lived Intangible Assets, Accumulated Amortization (10.5) (10.5)
Finite-lived Intangible Assets, Net $ 0.0 0.0
Intangible Assets, Estimated Life (months) 7 years  
Purchased Technology [Member]    
Intangible Assets [Line Items]    
Finite-lived Intangible Assets, Cost $ 4,710.5 4,710.5
Finite-lived Intangible Assets, Accumulated Amortization (1,388.7) (1,079.1)
Finite-lived Intangible Assets, Net 3,321.8 3,631.4
Other Intangibles [Member]    
Intangible Assets [Line Items]    
Finite-lived Intangible Assets, Cost 0.4 0.4
Finite-lived Intangible Assets, Accumulated Amortization (0.2) (0.2)
Finite-lived Intangible Assets, Net $ 0.2 $ 0.2
Intangible Assets, Estimated Life (months) 5 years  
Minimum | Licensing Agreements    
Intangible Assets [Line Items]    
Intangible Assets, Estimated Life (months) 3 years  
Minimum | Purchased Technology [Member]    
Intangible Assets [Line Items]    
Intangible Assets, Estimated Life (months) 6 years  
Maximum | Licensing Agreements    
Intangible Assets [Line Items]    
Intangible Assets, Estimated Life (months) 8 years  
Maximum | Purchased Technology [Member]    
Intangible Assets [Line Items]    
Intangible Assets, Estimated Life (months) 16 years  
Synageva BioPharma Corp. [Member] | Purchased Technology [Member]    
Intangible Assets [Line Items]    
Finite-lived Intangible Assets, Net $ 2,992.4